CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 43 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-04 | BAUM MARK L Chief Executive Officer | Returned to the company · Employee Stock Option - Right to Buy | −600,000 | 0 | ||
| 2020-06-04 | BAUM MARK L Chief Executive Officer | Grant or award · Employee Stock Option - Right to Buy | +600,000 | 600,000 | ||
| 2020-06-04 | Opaleye Management Inc. 10% owner | Purchase | +10,000 | $5.79 | $58K | 2,550,000 |
| 2020-06-03 | Opaleye Management Inc. 10% owner | Purchase | +20,600 | $5.74 | $118K | 2,540,000 |
| 2020-06-02 | Opaleye Management Inc. 10% owner | Purchase | +19,400 | $5.69 | $110K | 2,519,400 |
| 2020-05-22 | Opaleye Management Inc. 10% owner | Purchase | +8,804 | $5.05 | $44K | 2,500,000 |
| 2020-05-22 | Opaleye Management Inc. 10% owner | Purchase | +5,000 | $5.02 | $25K | 125,000 |
| 2020-05-21 | Opaleye Management Inc. 10% owner | Purchase | +10,396 | $4.66 | $48K | 2,491,196 |
| 2020-05-21 | Opaleye Management Inc. 10% owner | Purchase | +200 | $4.70 | $940 | 120,000 |
| 2020-05-20 | Opaleye Management Inc. 10% owner | Purchase | +300 | $4.47 | $1K | 2,480,800 |
| 2020-05-20 | Opaleye Management Inc. 10% owner | Purchase | +1,200 | $4.50 | $5K | 119,800 |
| 2020-03-16 | Sparks Teresa Director | Grant or award · RSU | +10,000 | 10,000 | ||
| 2020-03-16 | AUSTIN STEPHEN G Director | Option exercise | +72,218 | 91,987 | ||
| 2020-03-16 | AUSTIN STEPHEN G Director | Option exercise · RSU | −9,715 | 0 | ||
| 2020-03-16 | AUSTIN STEPHEN G Director | Option exercise · RSU | −34,091 | 9,715 | ||
| 2020-03-16 | AUSTIN STEPHEN G Director | Option exercise · RSU | −15,723 | 43,806 | ||
| 2020-03-16 | AUSTIN STEPHEN G Director | Option exercise · RSU | −12,690 | 59,529 | ||
| 2020-01-02 | BAUM MARK L Chief Executive Officer | Grant or award · Option - Right to Buy | +217,500 | 217,500 | ||
| 2020-01-02 | BAUM MARK L Chief Executive Officer | Grant or award · Restricted Stock Unit | +88,000 | 88,000 | ||
| 2020-01-02 | BOLL ANDREW R. Chief Financial Officer | Grant or award · Option - Right to Buy | +57,000 | 57,000 |
Page 12 of 17 · 336 trades